Beximco Pharmaceuticals Ltd.
Manufacturer of generic drugs, APIs, and specialized products for global markets.
BXP | IL
Overview
Corporate Details
- ISIN(s):
- US0885792061
- LEI:
- 213800IMBBD6TIOQGB56
- Country:
- Bangladesh
- Address:
- N/A
- Website:
- https://www.beximcopharma.com
- Sector:
- Manufacturing
Description
Beximco Pharmaceuticals Ltd. is a manufacturer of generic drugs and active pharmaceutical ingredients (APIs). The company produces a broad portfolio of over 500 products across various therapeutic categories, with a focus on providing access to affordable medicines. It has established a strong market differentiation through a range of high-tech, specialized products, including metered-dose and dry powder inhalers. Serving numerous emerging and developed markets globally, its manufacturing facilities are accredited by major international regulatory authorities, including those of the USA, European Union, Australia, and Canada.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2021-12-08 08:00 |
Delivery of COVID-19 vaccine doses
|
English | HTML • 10.2 KB | ||
| 2021-12-02 08:00 |
Update on the supply of COVID-19 vaccine
|
English | HTML • 10.2 KB | ||
| 2021-11-24 08:43 |
Statement re: media comment
|
English | HTML • 11.4 KB | ||
| 2021-11-16 08:00 |
Notice of AGM
|
English | HTML • 16.7 KB | ||
| 2021-11-11 11:30 |
Results for First Quarter Ended 30 September 2021
|
English | HTML • 251.2 KB | ||
| 2021-11-09 08:00 |
Launch of world’s first generic molnupiravir
|
English | HTML • 13.4 KB | ||
| 2021-11-02 08:00 |
Results for the year ended 30 June 2021
|
English | HTML • 200.5 KB | ||
| 2021-10-21 13:36 |
Notification of Preliminary Results and AGM
|
English | HTML • 27.8 KB | ||
| 2021-10-11 08:00 |
Update on the supply of COVID-19 vaccine
|
English | HTML • 11.0 KB | ||
| 2021-10-01 08:00 |
Completion of Sanofi Bangladesh Acquisition
|
English | HTML • 11.6 KB | ||
| 2021-09-14 11:20 |
Sanofi Bangladesh Share Purchase Agreement signed
|
English | HTML • 14.3 KB | ||
| 2021-09-03 14:10 |
Acquisition Approved by Bangladesh Bank
|
English | HTML • 10.4 KB | ||
| 2021-08-25 19:01 |
Statement re: media comment
|
English | HTML • 10.6 KB | ||
| 2021-07-26 08:00 |
FDA approval for muscle relaxant drug Baclofen
|
English | HTML • 12.1 KB | ||
| 2021-07-07 15:23 |
Update on the supply of COVID-19 vaccine
|
English | HTML • 11.7 KB |
Automate Your Workflow. Get a real-time feed of all Beximco Pharmaceuticals Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Beximco Pharmaceuticals Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Beximco Pharmaceuticals Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
